MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$18,959K
Free Cash flow
-$6,095K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from sales of pre-funde...
Proceeds from the exercise of wa...
Redemption of debt securities
Others
Negative Cash Flow Breakdown
Purchases of debt securities
Net loss
Payments made for costs to acqui...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-7,730
-8,993
-5,720
-18,377
Share-based compensation
377
253
323
1,530
Amortization of intangible assets
5
5
5
20
Amortization of finance lease right-of-use assets
0
0
68
271
Amortization of operating lease right-of-use assets
98
95
93
351
Depreciation of fixed assets
147
141
123
484
Accrued interest receivable on promissory note receivable
20
20
19
62
Amortization of premiums/(accretion of discounts) on debt securities
71
79
9
-
Provision for credit losses
0
65
-
-
Impairment of intangible assets
2,503
2,500
-
-
Accounts receivable - trade
0
0
65
-
Prepaid expenses and other current assets
1,783
-254
-
-
Prepaid expenses - noncurrent
281
-
-
-
Prepaid expenses and other current assets
-
-
106
408
Security deposit
0
-16
-
-
Accounts payable
380
-29
495
1,831
Accrued expenses
415
567
-686
-758
Operating lease obligations
-124
-122
-117
-436
Contract liabilities
0
0
-50
250
Net cash used in operating activities
-6,084
-5,241
-5,665
-15,304
Purchases of debt securities
8,500
2,467
21,461
-
Payment received for interest and principal on promissory note receivable
-
-
-
758
Redemption of debt securities
5,400
-
-
-
Purchases of fixed assets
11
516
32
16
Net cash (used in) provided by investing activities
-3,111
-2,983
-21,493
742
Proceeds from sales of common stock
3,310
0
219
3,541
Proceeds from sales of pre-funded warrants
22,676
55,948
-
-
Proceeds from pre-funded warrants
-
-
50,006
6,246
Proceeds from the exercise of warrants
-
3,651
-
-
Proceeds from the exercise of warrants for common stock
7,870
-
-
-
Payments made for costs to acquire capital
2,051
194
3,465
294
Proceeds from the exercise of stock options
-
-
-
131
Subscription receivable
0
0
105
-
Payment of equipment financing loan
0
17
47
178
Payment of term promissory note
0
597
60
218
Payment of finance lease obligation
0
0
53
299
Net cash provided by financing activities
28,154
8,785
46,705
8,929
Net increase (decrease) in cash, cash equivalents and restricted cash
18,959
561
19,547
-5,633
Cash, cash equivalents and restricted cash - beginning
28,339
28,339
8,792
-
Cash, cash equivalents and restricted cash - end
47,859
28,900
28,339
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from sales of
pre-funded warrants
$22,676K
Proceeds from the
exercise of warrants for...
$7,870K
Proceeds from sales of
common stock
$3,310K
Net cash provided by
financing activities
$28,154K
Canceled cashflow
$5,702K
Net increase
(decrease) in cash, cash...
$18,959K
Canceled cashflow
$9,195K
something is missing
-$3,651K
Payments made for costs to
acquire capital
$2,051K
Impairment of intangible
assets
$2,503K
Accrued expenses
$415K
Accounts payable
$380K
Share-based compensation
$377K
Depreciation of fixed assets
$147K
Amortization of operating
lease right-of-use...
$98K
Amortization of intangible
assets
$5K
Redemption of debt
securities
$5,400K
Net cash used in
operating activities
-$6,084K
Net cash (used in)
provided by investing...
-$3,111K
Canceled cashflow
$3,925K
Canceled cashflow
$5,400K
Net loss
-$7,730K
Purchases of debt
securities
$8,500K
Prepaid expenses and
other current assets
$1,783K
Prepaid expenses -
noncurrent
$281K
Operating lease
obligations
-$124K
Amortization of
premiums/(accretion of discounts) on...
$71K
Accrued interest
receivable on promissory...
$20K
Purchases of fixed assets
$11K
Buy us a coffee
iBio, Inc. (IBIO)
iBio, Inc. (IBIO)